Presented as a poster at the 42nd Annual New Clinical Drug Evaluation Unit Meeting, Boca Raton, Fla., June 10–13, 2002. Received June 28, 2004; revision received Nov. 2, 2004; accepted Nov. 8, 2004. From the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; the Department of Psychiatry, VA Connecticut, West Haven; the Department of Health and Mental Hygiene, Bureau of Maternal, Infant, and Reproductive Health, New York; the Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, N.Y.; and the Department of Psychiatry, University of North Carolina, Chapel Hill. Address correspondence and reprint requests to Dr. Gunduz-Bruce, VA Medical Center, Psychiatry Service 118A, 950 Campbell Ave., West Haven, CT 06516; email@example.com (e-mail). Supported by NIMH grants MH-41646, MH-00537, and MH-41960. The authors thank Sabina Meyer for her contribution to data collection.